Delivery Order SPE2DB22D9367-SPE2DB24FSY55

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $35,521.98, is for the provision of 4565503731 - JAKAFI 10 MG TABLET 60S, with a performance period through August 20, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,794.12, is for the delivery of JAKAFI 20 MG TABLET 60S, a specialized pharmaceutical product. The delivery order was awarded under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,773.87 firm fixed-price delivery order is for the supply of JAKAFI 15 MG TABLET 60S, and is part of a larger $499,999,999 indefinite delivery contract (IDC) that allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $35,388.40 for the supply of JAKAFI 15 MG TABLET 60S. The contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $120,561.77, is for the delivery of 4558971271 - JAKAFI 10 MG TABLET 60S. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $35,321.61 and covers the delivery of 4564676050 - JAKAFI 15 MG TABLET 60S, a specialized pharmaceutical product, with a period of performance through May 22, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program. The...
This firm fixed-price delivery order from the Defense Logistics Agency (DLA) was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $35,549.43 contract is for the supply of JAKAFI 5 MG TABLET 60S, a branded prescription medication, with a period of performance through September 10, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,115.65, is for the delivery of JAKAFI 10 MG TABLET 60S, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 contract is for the delivery of JAKAFI 10 MG TABLET 60S, a specialized prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSY55
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $23,547.74, is for the delivery of JAKAFI 15 MG TABLET 60S.

The award is part of a larger indefinite delivery contract (IDC) under the DLA's SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds this IDC contract and also has separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites.

The contract does not have a set-aside designation. DMS Pharmaceutical Group's status as a woman-owned small business has enabled it to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.

Generated 10/4/24, 9:17 AM